Form D · Pharmaceuticals

Palladium Life Sciences, LLC

Chicago, IL · CIK 0001580788

Offering snapshot reported Sep 10, 2013 · SEC filing

Reported sold
$4.04M
Offering amount: $4.16M
Investors reported
12
Form D · investor count
Minimum accepted
$160K
Reported outside-investor minimum
First sale
Jul 8, 2013
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.02M$4.04MJul 10, 2013: $1,800,000.00Jul 10, 2013Sep 10, 2013: $4,043,488.00Sep 10, 2013

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,800,000 → $4,043,488
  • Reported investors5 → 12
  • Minimum accepted$260,000 → $160,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 10, 2013Amendment$4,043,488$2,243,488vs Jul 10, 201312SEC filing
Jul 10, 2013Initial$1,800,000No comparison5SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-199314

Source: Form D, filed Sep 10, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Rajin Ahuja Executive
R K Ahuja Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
833 W 15 Th Pl Unit 901
Chicago, IL, 60608